|
(b)(4).This is a combination product and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.To date it has been reported that the device will not be returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Component code: (b)(4).A manufacturing record evaluation was performed for the finished device batch and no non-conformances were identified.Trade name - irgacare®, active ingredient(s) ¿ triclosan, dosage form ¿ suture/solid/parenteral, strength ¿ = 275 g/m.Related events captured via: 2210968-2022-10483.
|
|
It was reported that an animal underwent an oophorectomy procedure on (b)(6) 2022 and suture was used.During the overlock of the abdominal wall, after a few tissue passages and without exerting excessive pressure, the needle pulled off from the thread.The procedure was completed using a new device, without affecting the animal.No further information was available.
|